Pages that link to "Q51989994"

The following pages link to Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine (Q51989994):

Displaying 28 items.

• Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging (Q24563935) (← links)
• Biomarkers of Alzheimer's disease (Q24650667) (← links)
• Neuroimaging biomarkers of neurodegenerative diseases and dementia (Q27691820) (← links)
• Magnetic resonance imaging and magnetic resonance spectroscopy in dementias (Q30660816) (← links)
• Imaging Alzheimer's disease (Q30817949) (← links)
• Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease (Q30983010) (← links)
• Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease (Q33517035) (← links)
• Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity (Q33925140) (← links)
• The blood-brain barrier and microvascular water exchange in Alzheimer's disease. (Q33936586) (← links)
• Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease. (Q34245127) (← links)
• A summary risk score for the prediction of Alzheimer disease in elderly persons (Q34747831) (← links)
• Is the cerebellum the optimal reference region for intensity normalization of perfusion MR studies in early Alzheimer's disease? (Q35079958) (← links)
• Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease (Q35236542) (← links)
• Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). (Q35781558) (← links)
• Correlation of CT perfusion and CT volumetry in patients with Alzheimer's disease (Q36076645) (← links)
• Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment (Q36773815) (← links)
• Method for rapid calculation of quantitative cerebral perfusion (Q37216293) (← links)
• On the measurement of absolute cerebral blood volume (CBV) using vascular-space-occupancy (VASO) MRI. (Q37315144) (← links)
• Linking hippocampal structure and function to memory performance in an aging population (Q37424713) (← links)
• Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection (Q37639158) (← links)
• Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease (Q37695322) (← links)
• GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease (Q38225536) (← links)
• Evaluation of flow measurement from the first pass bolusT1weighted images using inversion recovery sequence (Q41975277) (← links)
• Compromised hemodynamic response in amyloid precursor protein transgenic mice. (Q44102454) (← links)
• Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia. (Q52936773) (← links)
• „Mild cognitive impairment“ (Q56637377) (← links)
• Decision modelling of non-pharmacological interventions for individuals with dementia: a systematic review of methodologies (Q88184726) (← links)
• Differentiating between Alzheimer's disease, amnestic mild cognitive impairment, and normal aging via diffusion kurtosis imaging (Q92518475) (← links)